Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiological projections of viral‐induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination
Erwan Vo Quang, Yusuke Shimakawa, Pierre Nahon
Liver International (2021) Vol. 41, Iss. 5, pp. 915-927
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
Advances in multi-omics research on viral hepatitis
Ze Xiang, Jiayuan Li, Di Lu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study
Jiping Yao, Xue Liang, Yanning Liu, et al.
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 22
Both Full-Length and Protease-Cleaved Products of Osteopontin Are Elevated in Infectious Diseases
Toshio Hattori, Hiroko Iwasaki, Gaowa Bai, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 24
Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan
Chun‐Ju Chiang, Jing‐Rong Jhuang, Ya‐Wen Yang, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2222367-e2222367
Open Access | Times Cited: 17
SPINK13 acts as a tumor suppressor in hepatocellular carcinoma by inhibiting Akt phosphorylation
Yongzhi Lun, Jie Sun, Ling Wei, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 2
Synthetic Tryptanthrin Derivatives Induce Cell Cycle Arrest and Apoptosis via Akt and MAPKs in Human Hepatocellular Carcinoma Cells
Jing-Yan Gao, Chih‐Shiang Chang, Jin‐Cherng Lien, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1527-1527
Open Access | Times Cited: 13
CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
Kun He, Mengyi Xie, Jingdong Li, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 7493-7510
Open Access | Times Cited: 8
Viral Infections of the Fetus and Newborn
Caleb Stokes, Ann J. Melvin
Elsevier eBooks (2023), pp. 450-486.e24
Closed Access | Times Cited: 4
Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study
Hind A. Beydoun, Jack Tsai
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 10, pp. 601-613
Closed Access | Times Cited: 1
Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques
Shivani Kale, Geeta Karande, Anand Gudur, et al.
Cureus (2024)
Open Access | Times Cited: 1
Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis
Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 7204-7225
Open Access | Times Cited: 1
Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma
Yuhong Suo, Chunyu Hou, Guang Yang, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 3
Identification of potential pseudogenes for predicting the prognosis of hepatocellular carcinoma
Luqi Ge, Tiefeng Jin, Wanli Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 14255-14269
Open Access | Times Cited: 3
Mapping evidence on the risk factors associated with pediatric cancers in sub-Saharan Africa: a scoping review
Sehlisiwe R. Ndlovu, Mbuzeleni Hlongwa, Themba G. Ginindza
Systematic Reviews (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals
Ginny Jacobs, Deborah A. Boyle, Hashem B. El–Serag, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3670-3683
Open Access | Times Cited: 4
Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa
Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 4
L-distance ratio: a new distance ratio-based evaluation method for the diagnosis of cirrhosis using enhanced computed tomography
Huifen Ye, Qiushi Wang, Haitao Huang, et al.
Quantitative Imaging in Medicine and Surgery (2023) Vol. 13, Iss. 3, pp. 1499-1509
Open Access | Times Cited: 2
Review: Challenges of In Vitro CAF Modelling in Liver Cancers
Alba Herrero, Elisabeth Knetemann, Inge Mannaerts
Cancers (2021) Vol. 13, Iss. 23, pp. 5914-5914
Open Access | Times Cited: 5
Upregulated SSB Is Involved in Hepatocellular Carcinoma Progression and Metastasis through the Epithelial-Mesenchymal Transition, Antiapoptosis, and Altered ROS Level Pathway
Hao Wu, Zhixin Zhang, Xinyu Han, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 1
Assessment of hepatocellular carcinoma surveillance practices in Africa
Manaswita Tappata, Marina Farah, Chimaobi M. Anugwom, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 697-698
Closed Access | Times Cited: 1
Gastrodia elata rhizoma ameliorates thioacetamide-induced liver injury in dogs
Hye-Bin Yoon, Jeong-Hwi Cho, Jung Soo Kim, et al.
Journal of Advanced Veterinary and Animal Research (2023) Vol. 10, Iss. 2, pp. 144-144
Open Access | Times Cited: 1
Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer prevention
Spencer Goble, Ângelo Zambam de Mattos, Manuel Mendizábal, et al.
Annals of Hepatology (2023) Vol. 28, Iss. 6, pp. 101149-101149
Open Access | Times Cited: 1
Comparison of post-resection survival between hepatocellular carcinoma patients in BCLC stage A or B who experience tumor rupture and patients in BCLC stage C who do not
Su Jia-Yong, Hongliang Wang, Luo Ding-Wen, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27355-e27355
Open Access
PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
Wenzhi Jin, Ganggang Wang, Meiyuan Dong, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top